ESMO Deep Dive: Lower Digestive Cancers
ESMO Deep Dive: Lower Digestive Cancers
This new webinar series delivers to the oncologist who has mastered a background knowledge of diagnostic approach, risk stratification and management of patients with lower digestive cancers, a second, deeper layer of educational experience in emerging data related to:
- molecular biology and classification
- translational research and biomarkers for precision medicine
- unknowns, hypotheses and ongoing research in areas of controversy or unmet need for optimal management of patients
Upon completion of the series, health professionals will:
- Have a better understanding of mechanisms of action of targeted therapies
- Optimise management of patients in clinical scenarios of controversy or unknowns
- Enhance patient selection to maximise benefit from innovative therapeutics
- Gain a clearer vision of disease and appreciation of progress made and challenges faced
Programme 2023
- February - Rectal Cancer
- March - Localised Colorectal Cancer and Molecular Tools
- April - Controlling Oligometastatic Colorectal Cancer
- May - Metastatic Colorectal Cancer with Molecular Drivers
- June - Dmmr/Msi-H Colorectal Cancer
- July - Metastatic Colorectal Cancer without Molecular Drivers
- September - Anal Cancer: Insights
Each webinar offers the opportunity for live real-time interaction between audience and experts.
A certificate of attendance and 2 ESMO-MORA category 1 points will be awarded for live attendance to these webinars.
The recordings are available to all ESMO Members a few days after the live event.
Supported by
On Demand Resources
Breakthroughs in Systemic Therapies for Metastatic CRC Patients without Oncogenic Drivers or Hypermutated Phenotype 2023
Immuno-Oncology in dMMR/MSI-H Colorectal Cancer: Promises and Challenges
Insights from Biology and Clinical Research in the Management of Patients with Molecularly-Defined Subgroups of Metastatic CRC
The Practice and Promise of Locoregional Therapies for the Management of Patients with Oligometastatic Colorectal Cancers
Molecular Selection and Monitoring of Adjuvant Strategies for Patients with Colorectal Cancer: Tissue, Liquid and Combos